Crystalvue Medical Corporation Stock

Equities

6527

TW0006527005

Medical Equipment, Supplies & Distribution

End-of-day quote Taipei Exchange 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
77.5 TWD +0.52% Intraday chart for Crystalvue Medical Corporation -2.64% -10.61%
Sales 2024 * 961M 29.47M Sales 2025 * - Capitalization 1.96B 60.05M
Net income 2024 * 138M 4.23M Net income 2025 * - EV / Sales 2024 * 2.04 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
14.3 x
P/E ratio 2025 *
-
Employees 109
Yield 2024 *
-
Yield 2025 *
-
Free-Float 61.8%
More Fundamentals * Assessed data
Dynamic Chart
Crystalvue Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Crystalvue Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Crystalvue Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Crystalvue Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Crystalvue Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
AUO Display Plus Corporation made a tender offer to acquire additional 25% minority stake in Crystalvue Medical Corporation CI
Crystalvue Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Crystalvue Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Crystalvue Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Crystalvue Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Crystalvue Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Crystalvue Medical Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Crystalvue Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Crystalvue Medical Corporation Reports Earnings Results for the Third Quarter Ended September 30, 2020 CI
Crystalvue Medical Corporation Reports Earnings Results for the Second Quarter Ended June 30, 2020 CI
More news
1 day+0.52%
1 week-2.64%
Current month-7.30%
1 month-7.41%
3 months-10.61%
6 months-10.92%
Current year-10.61%
More quotes
1 week
77.00
Extreme 77
79.20
1 month
77.00
Extreme 77
84.70
Current year
77.00
Extreme 77
88.40
1 year
68.38
Extreme 68.381
118.57
3 years
38.48
Extreme 38.4762
118.57
5 years
38.10
Extreme 38.0952
118.57
10 years
22.08
Extreme 22.0762
118.57
More quotes
Managers TitleAgeSince
Chief Executive Officer - 12-04-05
Director of Finance/CFO - -
President - 14-07-20
Members of the board TitleAgeSince
Chief Executive Officer - 12-04-05
Director/Board Member 55 10-07-04
Director/Board Member - 15-06-24
More insiders
Date Price Change Volume
24-04-22 77.5 +0.52% 24,456
24-04-19 77.1 -1.28% 95,388
24-04-18 78.1 +0.13% 50,417
24-04-17 78 -0.64% 51,568
24-04-16 78.5 -1.38% 56,084

End-of-day quote Taipei Exchange, April 21, 2024

More quotes
Crystalvue Medical Corporation is mainly engaged in the research, development, manufacture and sale of ophthalmic diagnostic medical devices. Its businesses include the manufacture of medical equipment, optical devices, precision instruments, the wholesale of computer and peripherals, electronic materials, international trading business, the provision of data processing service, electronic information and other related services.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
77.5 TWD
Average target price
92 TWD
Spread / Average Target
+18.71%
Consensus